An orally available inhibitor of microtubule polymerization (IC50 = ~3 μM) that blocks cell cycling at the G2-M phase, which leads to cell death; cytotoxic to a range of cancer cell lines (IC50s = 9-101 nM) and demonstrates antivascular activity in tumors both in vitro and in vivo